Stroke Prevention in Atrial Fibrillation in the Very Elderly: Anticoagulant Therapy Is No Longer a Sin
- PMID: 28736386
- PMCID: PMC5586331
- DOI: 10.1161/JAHA.117.006864
Stroke Prevention in Atrial Fibrillation in the Very Elderly: Anticoagulant Therapy Is No Longer a Sin
Keywords: Editorials; anticoagulation; atrial fibrillation; elderly.
Comment on
-
Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub-Analysis From the PREFER in AF (PREvention oF Thromboembolic Events-European Registry in Atrial Fibrillation).J Am Heart Assoc. 2017 Jul 23;6(7):e005657. doi: 10.1161/JAHA.117.005657. J Am Heart Assoc. 2017. PMID: 28736385 Free PMC article.
References
-
- Brophy MT, Snyder KE, Gaehde S, Ives C, Gagnon D, Fiore LD. Anticoagulant use for atrial fibrillation in the elderly. J Am Geriatr Soc. 2004;52:1151–1156. - PubMed
-
- Ogilvie IM, Newton M, Welner SA, Cowell W, Lip GYH. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med. 2010;123:638–645. - PubMed
-
- Hylek EM, Evans‐Molina C, Shea C, Henault LE, Regan S. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation. 2007;115:2689–2696. - PubMed
-
- Bertozzo G, Zoppellaro G, Granziera S, Marigo L, Rossi K, Petruzzellis F, Perissinotto E, Manzato E, Nante G, Pengo V. Reasons for and consequences of vitamin K antagonist discontinuation in very elderly patients with non‐valvular atrial fibrillation. J Thromb Haemost. 2016;14:2124–2131. - PubMed
-
- Kooistra HAM, Calf AH, Piersma‐Wichers M, Kluin‐Nelemans HC, Izaks GJ, Veeger NJGM, Meijer K. Risk of bleeding and thrombosis in patients 70 years or older using vitamin K antagonists. JAMA Intern Med. 2016;176:1176–1183. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
